NSE: MRF | BSE: 500290

Falling Comet

Download real time

126390.00 -2705.00 (-2.10%)

9,023 NSE+BSE Volume

NSE 02 Apr, 2026 3:31 PM (IST)

53,603.3

Market Cap

Market Leader

Beta 1Year

Very Low volatility

MRF Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MRF, BSE:500290 MRF Ltd.

Search Inside the pdf :

MRF Ltd.

06 Feb 2026

126390.00

-2.10%

Strong performance

Sell: MRF Ltd.

Target

Motilal Oswal

MRF’s 3QFY26 Adj PAT at INR7.3b was well ahead of our estimates of INR5.5b. This was largely attributed to strong operating performance, with EBITDA margins expanding 550bp YoY to 17.2% (vs. our estimate of 15.3%).

Number of MF schemes increased from 92 to 110 in Dec 2025 qtr.

MRF Ltd.

12 Aug 2025

126390.00

-2.10%

Q1 miss; brighter margin outlook; maintaining a Buy

Buy: MRF Ltd.

Target

Anand Rathi

Below our estimate, MRF’s Q1 EBITDA fell 9% y/y to Rs10.3bn due to the lower-than-expected gross margin. We expect 9/13/19% revenue/ EBITDA/PAT growth over FY25-28.

MRF Ltd. is trading below all available SMAs

MRF Ltd.

10 Nov 2024

126390.00

-2.10%

Margins to expand ahead, upgrading to a Buy

Buy: MRF Ltd.

Anand Rathi

Broadly in line with our Rs9.7bn estimate, MRF’s Q2 EBITDA fell 14% y/y to Rs9.7bn.

Number of MF schemes increased from 92 to 110 in Dec 2025 qtr.

MRF Ltd.

05 May 2024

126390.00

-2.10%

Weak operational performance

Sell: MRF Ltd.

Target

Motilal Oswal

MRF’s 4QFY24 result was weak as higher RM costs and operating expenses
led to lower adjusted EBITDA margin of 16.2% (-100bp QoQ vs. est. 17%). A
provision of INR463.6m, which was made in FY23, was recognized in 4Q
along with the additional provision of INR981.4m for FY24 to cover EPR
costs.

MRF Ltd. is trading below all available SMAs

MRF Ltd.

04 Nov 2023, 12:00AM

126390.00

-2.10%

EBITDA in line despite a miss on revenue

Sell: MRF Ltd.

Target

Motilal Oswal

Number of MF schemes increased from 92 to 110 in Dec 2025 qtr.

MRF Ltd.

03 May 2023, 12:00AM

126390.00

-2.10%

Above est; benign RM costs aid margin expansion

Sell: MRF Ltd.

Recommendation Target

Motilal Oswal

MRF Ltd. has an average target of 149575.50 from 2 brokers.

MRF Ltd.

08 Nov 2022

126390.00

-2.10%

Below estimates; performance adversely impacted by higher costs

Neutral: MRF Ltd.

Target

Motilal Oswal

Number of FII/FPI investors increased from 709 to 739 in Dec 2025 qtr.

MRF Ltd.

09 Aug 2022

126390.00

-2.10%

Below our estimate; impacted by cost pressure and MTM losses

Neutral: MRF Ltd.

Target

Motilal Oswal

MRF Ltd. has an average target of 149575.50 from 2 brokers.

MRF Ltd.

10 May 2022

126390.00

-2.10%

Beat led by strong revenue growth

Neutral: MRF Ltd.

Target

Motilal Oswal

Number of FII/FPI investors increased from 709 to 739 in Dec 2025 qtr.

MRF Ltd.

09 Nov 2021

126390.00

-2.10%

Below est; Higher RM, other cost impact margins

Neutral: MRF Ltd.

Target

Motilal Oswal

MRFs sales grew weaker than peers due to weakness in TBB & Farm MRF's 2QFY22 performance was impacted by RM cost inflation and higher other cost. MRF lagged peers in revenue growth due to weaker performance of TBB and farm segment. The industry is taking gradual price increases to dilute impact of severe cost inflation. We cut our FY22E/FY23E EPS by ~29%/14% to factor in for RM cost inflation and higher other expenses. Maintain Neutral....

Number of MF schemes increased from 92 to 110 in Dec 2025 qtr.

Is MRF Ltd. worth buying?

642 Votes:

Buy 56.85%

Sell 23.68%

Hold 19.47%

RESEARCH REPORTS

Sell SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf